Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:https://ncihub.cancer.gov/groups/ncihubshutdown/overview
close

Resources: All

Submit a resource

Find a resource
  1. isatabnano x
  2. breastcancer x

  1. ISA-TAB-Nano 1.3 release review

    0.0 out of 5 stars 

    09 Mar 2020 | Contributor(s): Mervi Heiskanen, Mervi Anneli Heiskanen

    Nano WG January 30th, 2020Review of the new 1.3 release with the Nano WG

  2. ISA-TAB-Nano-Expanded: Community-Sourced Updated Templates

    0.0 out of 5 stars 

    22 Sep 2017 | Presentations | Contributor(s): Nancy Birkner

    Nano WG Presentation September 21, 2017 by Nancy Birkner, Duke University. ISA-TAB-Nano extension project with added support for environmental, health and safety assessment of nanomaterials. Center for the Environmental Implications of Nanotechnology (CEINT) took on the leadership of...

  3. NANoREG-Proposed ISA-TAB-Nano Template Expansion

    0.0 out of 5 stars 

    13 Apr 2017 | Presentations | Contributor(s): Nancy Birkner

    Nano WG presentation April 13, 2017 by Dr. Nancy Birkner, post-doctoral associate at Duke University working in conjunction with the NanoInformatics Knowledge Commons, presented her progress on reviewing and updating the ISA-TAB-Nano data exchange formats. Dr. Birkner described the evolution of...

  4. Community Adoption & Adaptation of ISA-TAB-nano Data Sharing Templates: A brief overview, next steps at CEINT, and an open discussion of priority actions

    0.0 out of 5 stars 

    09 Feb 2017 | Presentations | Contributor(s): Christine Ogilvie Hendren, Nancy Birkner

    Nano WG meeting on February 2nd, 2017 ISA-TAB-Nano Next Steps 

  5. eNanoMapper Database, Search Tools and Templates

    0.0 out of 5 stars 

    23 Nov 2016 | Presentations | Contributor(s): Nina Jeliazkova

    Nano WG presentation, November 17, 2016

  6. Integrative Cancer Biology Program Datasets

    0.0 out of 5 stars 

    26 Apr 2016 | Series | Contributor(s): Jonathan Bistline, Michael Reich

    The NCI-ICBP promotes an integrative/systems approach to the study of cancer biology. The Program encourages scientists to study cancer as a complex biological system. Information gained from these studies are used to build reliable and testable predictive computation models of cancer processes...

  7. Breast Cancer Crossword

    0.0 out of 5 stars 

    20 Nov 2015 | Teaching Materials | Contributor(s): Katelyn Schifano

    This crossword is designed for use in social media as well as patient waiting areas.

  8. Screening for Small Molecules: Target Discovery Against miRNAs for Breast Cancer Treatment

    0.0 out of 5 stars 

    18 Aug 2015 | Presentations | Contributor(s): Odemaris Narvaez del Pilar

    Breast cancer is one of the leading causes of cancer related deaths and morbidity among women worldwide. Identifying new targets and developing new therapies is very important in order to improve patient outcomes and minimize this health burden. MicroRNAs, a type of non-coding RNA, are potential...

  9. LBL ICBP50 integrative genomic data

    0.0 out of 5 stars 

    13 Nov 2014 | Downloads | Contributor(s): Joe Gray, Jonathan Bistline

    From Joe Gray, Lawrence Berkeley National Laboratory.  There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...

  10. Baylor Residual breast cancer

    0.0 out of 5 stars 

    13 Nov 2014 | Downloads | Contributor(s): Creighton C, Lewis M, Chang J, Jonathan Bistline

    Residual breast cancers after conventional therapy display mesenchymal as tumor-initiating features.  There are four (4) files included in this study: Sample Annotation (combined_sample_annotation.txt) Gene expression data from CD44+/CD24- cells sorted by flow cytometry (GSE7513.gct) Human...

  11. Integrated analysis of breast cancer cell lines reveals unique signaling pathways

    0.0 out of 5 stars 

    16 Sep 2014 | Publications | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman

    AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...